SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-003544
Filing Date
2019-03-04
Accepted
2019-03-04 17:20:57
Documents
18
Period of Report
2019-03-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k030419_intecpharma.htm 8-K 16487
2 INTEC PHARMA LTD. SLIDE PRESENTATION, DATED MARCH 2019 f8k030419ex99-1_intecpharma.htm EX-99.1 17803
3 GRAPHIC image_001.jpg GRAPHIC 55986
4 GRAPHIC image_002.jpg GRAPHIC 165576
5 GRAPHIC image_003.jpg GRAPHIC 88251
6 GRAPHIC image_004.jpg GRAPHIC 89220
7 GRAPHIC image_005.jpg GRAPHIC 70877
8 GRAPHIC image_006.jpg GRAPHIC 79118
9 GRAPHIC image_007.jpg GRAPHIC 58425
10 GRAPHIC image_008.jpg GRAPHIC 68428
11 GRAPHIC image_009.jpg GRAPHIC 61277
12 GRAPHIC image_010.jpg GRAPHIC 77077
13 GRAPHIC image_011.jpg GRAPHIC 53901
14 GRAPHIC image_012.jpg GRAPHIC 52061
15 GRAPHIC image_013.jpg GRAPHIC 64719
16 GRAPHIC image_014.jpg GRAPHIC 48479
17 GRAPHIC image_015.jpg GRAPHIC 70807
18 GRAPHIC image_016.jpg GRAPHIC 81812
  Complete submission text file 0001213900-19-003544.txt   1670580
Mailing Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512
Business Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512 97225864657
Intec Pharma Ltd. (Filer) CIK: 0001638381 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37521 | Film No.: 19655137
SIC: 2834 Pharmaceutical Preparations